The European Bank for Reconstruction and Development (EBRD) has agreed to provide a €6mn ($7.2mn) senior secured loan, with a year-and-a-half grace period, to Lamatem to support a new capex programme for the production of medical garments and single-use personal protective equipment, in response to changing markets demand caused by the coronavirus (COVID-19) pandemic.
Lamatem's existing facility that produces high-end medical garments was supported by a first EBRD loan to the tune of €7.7mn extended in 2019. The facility started operations in the third quarter of 2019, mainly as a toll manufacturer for Molnlycke, a leading global supplier of medical solutions based in Sweden. In response to the changing market environment, Lamatem has now launched a new capex programme to meet increasing demand from Moroccan clinics and its new European clients. The programme also includes new product segments which require a sterilisation process.
Lamatem is an export-oriented company established in 2016 near Casablanca to produce high-end medical garments, fully owned by the Badaa family. The total project cost for the existing and new facility is €20.7mn supported by €12.7mn financing from EBRD.
Related Articles
Iraq holds talks with Excelerate Energy on buying first LNG from US
Iraq is in the final stages of negotiating its first-ever purchase of LNG supplies as power outages hamper the Middle East country, Bloomberg reported on June 26. Dallas-headquartered Excelerate ... more
Reformist Kamil al-Tayeb Idris appointed as Sudan’s new Prime Minister
Sudan’s Sovereign Council head, Abdel Fattah al-Burhan, issued a constitutional decree on May 19 appointing Kamil al-Tayeb Idris as the new prime minister, Al Sharq Al Awsat reported. He also ... more
Egypt examines LNG supply offers from Saudi Aramco, UAE’s Adnoc, Algeria’s Sonatrach, and QatarEnergy
Egypt's state-owned gas company EGAS has received several offers to supply liquefied natural gas (LNG) shipments urgently needed for summer, Al Sharq reported on May 18, citing an unnamed government ... more